Regarding PoPH and considering the high fatality rate associated with this PAH subtype (216), BMP9 may constitute an important tool for clinical screening of high-risk populations; nonetheless, more studies evaluating biomarker performance are still needed to validate these new concepts. Here, GDF2 is linked to pulmonary arterial hypertension.